Skip to main content
Search
Main content
Illustration of red blood cell in vessel

Vascular dementia

What is vascular dementia? 

Vascular dementia is one of the most common types of dementia, affecting around 180,000 people in the UK1.

It differs from other types of dementia because it is caused by conditions that reduce or block blood flow to the brain. This deprives brain cells of the oxygen and nutrients they need to function properly, leading to irreversible damage. This loss of brain cells can lead to a variety of problems for people living with the condition.

Vascular dementia cannot currently be cured, but treatments targeting the underlying causes of the reduced blood flow to the brain can help reduce the risk of further damage to brain tissue.

Woman with older parents sitting on sofa

Frequently asked questions

How common is vascular dementia?
What are the symptoms of vascular dementia?
How is vascular dementia diagnosed?
What treatments are there for vascular dementia?
How can I get involved in research and trials for vascular dementia?
What support is available for people affected by vascular dementia?

What are the causes of vascular dementia?

This type of dementia is caused by reduced blood flow to the brain, which deprives brain cells of the oxygen and nutrients they need to function properly. This reduction in blood flow can result from a variety of conditions, such as stroke, small vessel disease, or other issues that damage blood vessels, and it can lead to significant cognitive impairment, especially if multiple strokes occur over time.

Small vessel disease is one of the most common causes of vascular dementia. It refers to blockages (usually due to high blood pressure, high cholesterol and/or high blood sugar) in tiny vessels deep within the brain, which lead to tiny areas of damage. This damage usually goes unnoticed at first, but over time these tiny areas can progressively accumulate, leading to gradual slowing of thinking and other cognitive problems.

Interest in the vascular contributions to neurodegeneration has intensified in recent years. Our researchers and clinicians are combining their wealth of expertise in this research area to decipher the fundamental biology underlying vascular contributions to disease and where potential treatment opportunities may lie.

Surrounding our brain is the richest and most specialised blood vessel network in the body, called the blood-brain barrier (BBB). It is composed of multiple cell types, which act together to create an extremely selective barrier and maintain the optimal microenvironment for the brain it protects. Its dysfunction and breakdown are implicated in the earliest stages of several neurodegenerative conditions. Our researchers are investigating why this occurs with the aim of finding ways to support this specialised structure into age and as these diseases progress. Find out more about vascular contributions to dementia on our topic page.

There is growing evidence that the reduced incidence of dementia in some countries is due to improved cardiovascular health3, as a result of interventions such as reducing hypertension. In addition to the development of new treatments, taking existing drugs and repurposing them to tackle dementia could offer a faster route to effective treatments. Promising results were recently seen in a study led by Prof Joanna Wardlaw showing that two cheap and common drugs used for other heart and circulatory diseases could be harnessed as the first specific treatment for people who experience a type of stroke linked to nearly half of all dementias.

To further support our ambitions in vascular research, in 2023 we established a partnership with the British Heart Foundation to develop the UK’s first research centre dedicated to finding new treatments to prevent and halt vascular dementia. Through cutting-edge research the centre aims to unravel the molecular and cellular mechanisms underlying vascular dementia and to develop targeted therapeutic interventions. Find out more about The BHF – UK DRI Centre for Vascular Dementia Research here.

Superintendent Radiographer Charlotte Jardine and colleague examines brain scans on a computer screen

Superintendent Radiographer Charlotte Jardine and colleague examines brain scans for signs of small vessel disease. Credit: Edinburgh Imaging Facility